<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Pertussis infection: Epidemiology, microbiology, and pathogenesis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Pertussis infection: Epidemiology, microbiology, and pathogenesis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Pertussis infection: Epidemiology, microbiology, and pathogenesis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Paul Cornia, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Benjamin A Lipsky, MD, FACP, FIDSA, FRCP (London), FRCPS (Glasg)</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Stephen B Calderwood, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sheldon L Kaplan, MD</a></dd><dt><span> </span>Deputy Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jane Givens, MD, MSCE</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sheila Bond, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 08, 2024.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H252274975"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Pertussis, also known as "whooping cough," is a highly contagious respiratory illness caused by <em>Bordetella pertussis</em>. A Chinese reference to "the cough of 100 days" by Chao Yuanfang in the early 7<sup>th</sup> century may have referred to pertussis [<a href="#rid1">1</a>]. In 1679, Sydenham named the illness pertussis, from the Latin term meaning "intense cough." These names describe the key clinical features of pertussis infection. However, the classic clinical manifestations of pertussis infection (paroxysmal cough, inspiratory whoop, and post-tussive emesis) are frequently absent in adolescents and adults.</p><p>The microbiology, epidemiology, and pathogenesis of pertussis are reviewed here. The clinical manifestations, diagnosis, management, and prevention of pertussis are discussed separately. (See  <a class="medical medical_review" href="/d/html/8045.html" rel="external">"Pertussis infection in adolescents and adults: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/5997.html" rel="external">"Pertussis infection in infants and children: Treatment and prevention"</a> and  <a class="medical medical_review" href="/d/html/5995.html" rel="external">"Pertussis infection in infants and children: Clinical features and diagnosis"</a>.)</p><p class="headingAnchor" id="H270844"><span class="h1">MICROBIOLOGY</span><span class="headingEndMark"> — </span>Pertussis is caused by the gram-negative coccobacillus <em>B. pertussis</em>, a strict human pathogen with no known animal or environmental reservoir [<a href="#rid2">2</a>]. The organism is fastidious, surviving only a few hours in respiratory secretions and thus requiring special media for culture.</p><p>Eight additional <em>Bordetella </em>species have been described: <em>B. parapertussis</em><em><sub>hu</sub></em>, <em>B. parapertussis</em><em><sub>ov</sub></em><em> </em>(ovine-adapted parapertussis), <em>B. bronchiseptica</em>, <em>B. avium</em>, <em>B. hinzii</em>, <em>B. holmesii</em>, <em>B. trematum</em>, and <em>B. petrii </em>[<a href="#rid3">3</a>]. Three of these species (<em>B. parapertussis</em>, <em>B. bronchiseptica</em>, and <em>B. holmesii</em>)<sub> </sub>can cause respiratory illness in humans. <em>B. parapertussis</em> may cause a spectrum of disease ranging from a nonspecific upper respiratory tract illness to classic pertussis (ie, clinically indistinguishable from that of <em>B. pertussis</em>) [<a href="#rid4">4,5</a>]. <em>B. bronchiseptica</em> causes respiratory infections in a variety of mammals; human infection most often occurs in immunocompromised hosts with animal exposure [<a href="#rid6">6</a>]. Unlike <em>B. pertussis</em>, <em>B. holmesii</em> may also cause bacteremia; asplenia is the most common risk factor, but other immunocompromising conditions have been reported [<a href="#rid7">7-11</a>].</p><p class="headingAnchor" id="H252274996"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Pertussis is a highly contagious respiratory illness. In adolescents and adults, infection may result in a protracted cough and is occasionally associated with substantial morbidity. In children, and particularly infants, morbidity is more often substantial, and the disease may be fatal.</p><p class="headingAnchor" id="H252275003"><span class="h2">Transmission</span><span class="headingEndMark"> — </span>The incubation period for <em>B. pertussis</em> ranges from 1 to 3 weeks but is most typically 7 to 10 days. This is in contrast with the shorter incubation period (one to three days) for viral upper respiratory infections associated with cough, such as the common cold.</p><p>Pertussis infection is spread via respiratory droplets, which are aerosolized by paroxysms of coughing [<a href="#rid12">12</a>]. In one study, approximately one-third of exposed individuals within households developed pertussis [<a href="#rid13">13</a>]. A systematic review of similar studies found that the proportion of household contacts with laboratory evidence of infection who were asymptomatic ranged from 5 to 56 percent, and 3 to 46 percent had a mild respiratory illness (ie, nonclassical symptoms of pertussis) [<a href="#rid14">14</a>]. Thus, asymptomatic infection appears to be common and may contribute to transmission of pertussis between household contacts. </p><p>Individuals with pertussis are considered infectious until they have completed five days of appropriate antibiotic treatment [<a href="#rid15">15-17</a>].</p><p class="headingAnchor" id="H252275010"><span class="h2">Incidence</span><span class="headingEndMark"> — </span>Prior to the introduction of a whole-cell vaccine in the United States in the late 1940s, pertussis was a devastating illness with a relatively high infant mortality rate. Widespread pertussis vaccination of children led to a dramatic decline in disease incidence, from a peak of more than 250,000 reported cases in 1934 to a nadir of 1010 cases in 1976  (<a class="graphic graphic_figure graphicRef83297" href="/d/graphic/83297.html" rel="external">figure 1</a>) [<a href="#rid18">18</a>].</p><p>Cyclical epidemics continue to occur every two to five years as they did in the prevaccine era. These epidemics have been superimposed on the steadily rising incidence in the United States and many other developed countries. The unchanged cyclical epidemic pattern of pertussis suggests that the overall circulation of <em>B. pertussis</em> in the population has not been affected by the vaccine [<a href="#rid19">19</a>].</p><p>In the prevaccine era, the highest rates of pertussis infection were reported in the spring and summer months, but this seasonal variation declined after vaccine introduction. Along with the ongoing overall increase in pertussis infection, reports suggest recurrent seasonality with the peak occurring in the summer months [<a href="#rid20">20,21</a>]. </p><p>Since the 1970s, there has been a steady increase in reported cases of pertussis in the United States [<a href="#rid22">22</a>]. In 2010, there were 27,550 reported cases and outbreaks in several states  (<a class="graphic graphic_figure graphicRef73317" href="/d/graphic/73317.html" rel="external">figure 2</a>) and in 2012, there were more than 48,000 cases [<a href="#rid23">23,24</a>]. Between 2000 and 2016, more than 330,000 cases were reported in the United States [<a href="#rid25">25</a>]. Because pertussis is underreported and underdiagnosed in adults, the actual incidence is likely substantially higher. This was demonstrated by a study including patients ≥18 years old who had not received pertussis vaccination in the last five years; the incidence of pertussis (based on seroepidemiologic studies) was substantially higher than the clinically reported incidence (0.84 versus 699 per 100,000 inhabitants) [<a href="#rid26">26</a>]. A retrospective cohort study was used to develop a machine-learning algorithm to identify undiagnosed or misdiagnosed episodes of pertussis in adolescent and adult patients. Compared to data from the Centers for Disease Control, the inclusion of cases of pertussis identified by the algorithm increased the estimated incidence in all the years studied. This was most dramatic in adolescents (who consistently had the highest rates), for whom the incidence was 110-fold higher. This highlights the extent of potential underreporting of the disease [<a href="#rid27">27,28</a>].</p><p>The cause for the rising incidence of pertussis is not fully understood. Possible explanations include increased clinician awareness, increased public health reporting, increased availability of more sensitive diagnostic tests (particularly polymerase chain reaction [PCR]), waning vaccine-induced immunity in adolescent populations (as immunity following vaccination or infection is not lifelong) [<a href="#rid29">29</a>], decreased use of pertussis vaccine, genetic changes in the circulating strains of pertussis, and a true increase in circulating <em>B. pertussis</em>. Widespread use of PCR testing has improved clinicians' ability to confirm the diagnosis [<a href="#rid30">30,31</a>]. Numerous reports indicate that waning immunity with the acellular pertussis vaccines (DTaP and Tdap) is playing a major role in the increased incidence [<a href="#rid25">25</a>].</p><p>Since 1997, acellular pertussis vaccine (DtaP) has been recommended for all five childhood doses (the last of which should be administered between ages four and six years). Prior to 1997, vaccination was with whole-cell pertussis vaccine (DTwP) [<a href="#rid32">32</a>]. The DTwP vaccine was effective in preventing childhood pertussis, although immunity gradually waned 5 to 10 years after completing the childhood series, resulting in risk for infection in adolescence and adulthood [<a href="#rid33">33,34</a>]. Because the incidence of local reactions (pain, redness, swelling) and systemic reactions (fever, anorexia) with DTwP was relatively high [<a href="#rid35">35</a>], acellular pertussis vaccines (DtaP) were introduced for childhood vaccination in the United States in the early 1990s. Clinical trial data suggest DtaP has similar efficacy to DTwP, with a lower incidence of adverse effects [<a href="#rid32">32,36</a>]; however, the currently available DtaP formulations offer less short-term protection than DTwP [<a href="#rid37">37</a>].</p><p>Since 2005, an increased risk of pertussis has been observed in the first cohort of children who received the DtaP series as they reach 7 to 10 years of age [<a href="#rid38">38</a>]. Similarly, several reports suggest that the immunity following administration of the fifth DtaP dose wanes more rapidly than expected [<a href="#rid39">39-42</a>], leaving a gap in immunity between the last childhood dose of DtaP and the Tdap booster vaccine (which is suggested to be administered at 11 to 12 years of age) [<a href="#rid43">43</a>]. Adolescents who received the <a class="drug drug_general" data-topicid="9373" href="/d/drug information/9373.html" rel="external">DtaP vaccine</a> in childhood appear to have a substantially higher risk of contracting pertussis than those who received the DTwP vaccine [<a href="#rid44">44,45</a>] and the duration of Tdap vaccine protection is less in adolescents who received Dtap in childhood (rather than DTwP) [<a href="#rid46">46</a>]. </p><p>Worldwide, 90 percent of the 30 to 50 million annual cases of pertussis occur in resource-limited countries. About 300,000 cases result in death [<a href="#rid47">47</a>], with mortality occurring predominantly in infants (who are too young to have received vaccination) and unvaccinated or undervaccinated children.</p><p class="headingAnchor" id="H252275017"><span class="h2">Evolving epidemiology</span><span class="headingEndMark"> — </span>In the United States, a substantial portion of the increasing incidence in reported pertussis cases since 1990 is attributable to increased rates of infection in adolescents and adults [<a href="#rid48">48-51</a>]. In the prevaccine era, more than 90 percent of reported cases of pertussis occurred in children &lt;10 years old [<a href="#rid49">49</a>]. In the late 1990s, about one-half of reported cases occurred in adolescents and adults [<a href="#rid18">18</a>]; similar rates are observed in data from 2000 to 2016 [<a href="#rid25">25</a>]. The incidence of reported pertussis cases among infants has steadily increased since 1980 [<a href="#rid25">25,52,53</a>].</p><p><em>B. pertussis</em> infection in adolescents and adults appears to be much more common than many clinicians appreciate [<a href="#rid30">30,54</a>]. This may be because the manifestations of pertussis are often less severe than in infants and children. Studies of adolescents and adults with cough illnesses lasting ≥1 week in nonoutbreak settings indicate that pertussis is responsible for 13 to 20 percent of cases; the overwhelming majority of these patients actually had a substantially longer duration of illness (&gt;3 weeks) [<a href="#rid30">30,55</a>]. The incidence of pertussis is quite low in adults with cough duration ≤4 weeks [<a href="#rid56">56</a>] (see  <a class="medical medical_review" href="/d/html/8045.html" rel="external">"Pertussis infection in adolescents and adults: Clinical manifestations and diagnosis", section on 'Adolescents and adults'</a>). A seroprevalence study of adults (age 20 to 39 years) in 14 European countries showed rates of infection ranging from 0.2 to 5.7 percent and rates of infection within the past few years as high as 13.9 percent across the countries [<a href="#rid57">57</a>]. </p><p>Adolescents and adults with unrecognized pertussis serve as a reservoir of infection for infants and children [<a href="#rid58">58</a>]. In the United States, one-half of infants with pertussis infection require hospitalization and nearly 90 percent of pertussis deaths occur in infants [<a href="#rid25">25</a>]. Epidemiologic studies have shown that most infants acquire the infection from adolescents and adults in their own household [<a href="#rid59">59-63</a>]. Siblings of infants have been identified as the most common identifiable source of transmission in one study [<a href="#rid64">64</a>], likely reflecting increased susceptibility to infection of children and adolescents who received the acellular pertussis vaccine.</p><p>Primate data suggest that the acellular pertussis vaccine may protect individuals from clinical disease, but asymptomatic or subclinical infection may still develop and result in spread to susceptible individuals [<a href="#rid65">65</a>]. Mathematical modeling suggests that this may be an important reason for the increase in incidence in the United States and United Kingdom [<a href="#rid66">66</a>]. Despite the introduction of acellular pertussis vaccines over 20 years ago the incidence of pertussis has been increasing in most parts of the world over the past decade, with a shift in cases from young children to fully vaccinated adolescents and adults, mainly driven by waning vaccine immunity [<a href="#rid67">67,68</a>]. </p><p>An important misconception is that childhood pertussis vaccination or prior infection confers lifelong immunity. Because protective immunity wanes, booster vaccination is recommended for adolescents (preferably at age 11 or 12), adults, and for women with each pregnancy. An economic model found that increased vaccination coverage for among United States adults aged ≥50 years would be favorable [<a href="#rid69">69</a>]. </p><p>Rates of vaccination with Tdap among adults in the United States, while improving slightly in recent years, are still under 25 percent [<a href="#rid70">70</a>]. Similarly, a seroepidemiology study in Hungary found that 85 percent of adults were seronegative for pertussis and therefore susceptible to infection [<a href="#rid71">71</a>]. (See  <a class="medical medical_review" href="/d/html/8044.html" rel="external">"Pertussis infection in adolescents and adults: Treatment and prevention"</a>.)</p><p class="headingAnchor" id="H7117016"><span class="h2">Risk factors for infection and severe disease</span><span class="headingEndMark"> — </span>Groups at highest risk of pertussis-related morbidity and mortality include infants (especially those younger than six months), young children who have not been fully immunized, and older adults (ie, aged &gt;65 years). In one study of patients with pertussis in the United States, adults &gt;65 years were frequently hospitalized (14.8 percent) and accounted for 4.8 percent of all pertussis-related deaths [<a href="#rid25">25</a>]. Among adults and adolescents hospitalized with pertussis, high rates of comorbid asthma and, in older adults, chronic obstructive pulmonary disease have been observed [<a href="#rid72">72</a>]. In a pneumonia surveillance study of &gt;19,000 patients in South Africa, <em>B. pertussis </em>was detected in 1.2 percent of patients.  </p><p>Obesity and pre-existing asthma have been associated with a higher likelihood of developing pertussis [<a href="#rid73">73</a>]. In one study of older teenagers and adults, household contact with a younger teenager increased the risk of pertussis, whereas professional contact with children &lt;1 year of age decreased the risk [<a href="#rid74">74</a>].</p><p>Although the cause is uncertain, an excess in the female incidence rate for pertussis infection across all age ranges and various time periods has been observed in several countries [<a href="#rid75">75</a>].</p><p class="headingAnchor" id="H269764"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span><em>B. pertussis</em> is transmitted via aerosolized respiratory droplets. It produces a number of biologically active substances and virulence factors that promote cellular attachment, cause local tissue damage or systemic manifestations, and interfere with host defense mechanisms  (<a class="graphic graphic_table graphicRef76173" href="/d/graphic/76173.html" rel="external">table 1</a>). After inhalation, the organism adheres to ciliated respiratory epithelial cells of the upper respiratory tract and nasopharynx. A variety of protein adhesins have been implicated in the attachment process; these demonstrate a substantial degree of redundancy [<a href="#rid3">3</a>]. Once attached, they induce local tissue damage via tracheal cytotoxin, dermonecrotic toxin, or adenylate cyclase; this destructive process, with loss of the protective respiratory cells, is likely responsible for microaspiration and therefore for the cough.</p><p>Histopathological analysis, using a novel immunohistochemical technique, of tissue samples obtained from cases of fatal pertussis infection in infants revealed intracellular organisms in alveolar macrophages as well as the ciliated respiratory epithelial cells [<a href="#rid76">76</a>]. This may explain the prolonged duration of cough. The most notable systemic laboratory manifestation is lymphocytosis, which is caused by pertussis toxin (PT). PT may also cause hyperinsulinemia with resultant hypoglycemia in young infants [<a href="#rid77">77,78</a>].</p><p>Following infection, antibodies to a variety of antigens develop, including PT, filamentous hemagglutinin, pertactin, fimbriae 2/3, lipopolysaccharide, and adenylate cyclase. Many of these antigens form the components of pertussis vaccines. Pertactin, a virulence factor that is thought to promote adherence of <em>B. pertussis</em> to the upper respiratory epithelium, is a pertussis acellular vaccine immunogen. A screening study of 1300 surveillance and outbreak isolates in the United States demonstrated a dramatic increase in pertactin-deficient <em>B. pertussis </em>isolates [<a href="#rid79">79</a>]. In addition, an association has been observed between prior (acellular) vaccination and infection with pertactin-deficient <em>B. pertussis</em>, suggesting that previously vaccinated individuals are more susceptible to this strain [<a href="#rid80">80</a>].</p><p class="headingAnchor" id="H252275031"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Microbiology</strong> –<strong> </strong><em>Bordetella pertussis</em> is a fastidious gram-negative coccobacillus that requires special media for culture. It is exclusively a human pathogen. (See <a class="local">'Microbiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The introduction of the whole-cell pertussis vaccine in the United States in the late 1940s led to a dramatic decline in disease incidence; however, the number of reported cases in the United States and many other countries has been steadily rising since the 1970s. The newer acellular pertussis vaccines appear to be less efficacious than the whole-cell vaccines used previously. (See <a class="local">'Incidence'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Adolescents and adults with unrecognized pertussis represent a reservoir of infection for infants and children, in whom infection is associated with substantially higher morbidity and mortality. This has implications for vaccine recommendations in adolescents and adults. (See <a class="local">'Evolving epidemiology'</a> above and  <a class="medical medical_review" href="/d/html/8044.html" rel="external">"Pertussis infection in adolescents and adults: Treatment and prevention", section on 'Vaccination'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Transmission and pathogenesis</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The incubation period for <em>B. pertussis </em>is typically one week but may be three weeks or longer. (See <a class="local">'Transmission'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><em>B. pertussis</em> is highly contagious and is transmitted via aerosolized respiratory droplets. After inhalation, the organism adheres to ciliated respiratory epithelial cells of the upper respiratory tract and nasopharynx, causing local tissue damage. (See <a class="local">'Pathogenesis'</a> above.)</p><p></p><p class="headingAnchor" id="H252275812"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Dr. Christopher Ohl, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Liang Y, Salim AM, Wu W, Kilgore PE. Chao Yuanfang: Imperial Physician of the Sui Dynasty and an Early Pertussis Observer? Open Forum Infect Dis 2016; 3:ofw017.</a></li><li class="breakAll">Cotter PA, Miller JF. Bordetella. In: Principles of bacterial pathogenesis, Groisman EA (Ed), Academic Press, Ltd, London 2001. p.619.</li><li><a class="nounderline abstract_t">Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 2005; 18:326.</a></li><li><a class="nounderline abstract_t">Cherry JD, Seaton BL. Patterns of Bordetella parapertussis respiratory illnesses: 2008-2010. Clin Infect Dis 2012; 54:534.</a></li><li><a class="nounderline abstract_t">Koepke R, Bartholomew ML, Eickhoff JC, et al. Widespread Bordetella parapertussis Infections-Wisconsin, 2011-2012: Clinical and Epidemiologic Features and Antibiotic Use for Treatment and Prevention. Clin Infect Dis 2015; 61:1421.</a></li><li><a class="nounderline abstract_t">Woolfrey BF, Moody JA. Human infections associated with Bordetella bronchiseptica. Clin Microbiol Rev 1991; 4:243.</a></li><li><a class="nounderline abstract_t">Weyant RS, Hollis DG, Weaver RE, et al. Bordetella holmesii sp. nov., a new gram-negative species associated with septicemia. J Clin Microbiol 1995; 33:1.</a></li><li><a class="nounderline abstract_t">Yih WK, Silva EA, Ida J, et al. Bordetella holmesii-like organisms isolated from Massachusetts patients with pertussis-like symptoms. Emerg Infect Dis 1999; 5:441.</a></li><li><a class="nounderline abstract_t">Rodgers L, Martin SW, Cohn A, et al. Epidemiologic and laboratory features of a large outbreak of pertussis-like illnesses associated with cocirculating Bordetella holmesii and Bordetella pertussis--Ohio, 2010-2011. Clin Infect Dis 2013; 56:322.</a></li><li><a class="nounderline abstract_t">Tartof SY, Gounder P, Weiss D, et al. Bordetella holmesii bacteremia cases in the United States, April 2010-January 2011. Clin Infect Dis 2014; 58:e39.</a></li><li><a class="nounderline abstract_t">Pittet LF, Emonet S, Schrenzel J, et al. Bordetella holmesii: an under-recognised Bordetella species. Lancet Infect Dis 2014; 14:510.</a></li><li><a class="nounderline abstract_t">Warfel JM, Beren J, Merkel TJ. Airborne transmission of Bordetella pertussis. J Infect Dis 2012; 206:902.</a></li><li><a class="nounderline abstract_t">Deen JL, Mink CA, Cherry JD, et al. Household contact study of Bordetella pertussis infections. Clin Infect Dis 1995; 21:1211.</a></li><li><a class="nounderline abstract_t">Craig R, Kunkel E, Crowcroft NS, et al. Asymptomatic Infection and Transmission of Pertussis in Households: A Systematic Review. Clin Infect Dis 2020; 70:152.</a></li><li><a class="nounderline abstract_t">Tiwari T, Murphy TV, Moran J, National Immunization Program, CDC. Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis: 2005 CDC Guidelines. MMWR Recomm Rep 2005; 54:1.</a></li><li><a class="nounderline abstract_t">Bergquist SO, Bernander S, Dahnsjö H, Sundelöf B. Erythromycin in the treatment of pertussis: a study of bacteriologic and clinical effects. Pediatr Infect Dis J 1987; 6:458.</a></li><li><a class="nounderline abstract_t">Bass JW, Klenk EL, Kotheimer JB, et al. Antimicrobial treatment of pertussis. J Pediatr 1969; 75:768.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Pertussis--United States, 1997-2000. MMWR Morb Mortal Wkly Rep 2002; 51:73.</a></li><li><a class="nounderline abstract_t">Mink CM, Cherry JD, Christenson P, et al. A search for Bordetella pertussis infection in university students. Clin Infect Dis 1992; 14:464.</a></li><li><a class="nounderline abstract_t">Bhatti MM, Rucinski SL, Schwab JJ, et al. Eight-Year Review of Bordetella pertussis Testing Reveals Seasonal Pattern in the United States. J Pediatric Infect Dis Soc 2017; 6:91.</a></li><li><a class="nounderline abstract_t">Hitz DA, Tewald F, Eggers M. Seasonal Bordetella pertussis pattern in the period from 2008 to 2018 in Germany. BMC Infect Dis 2020; 20:474.</a></li><li class="breakAll">Centers for Disease Control and Prevention. MMMWR. Notifiable Diseases and Mortality Tables. April 20, 2012. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6115md.htm?s_cid=mm6115md_w (Accessed on April 30, 2012).</li><li><a class="nounderline abstract_t">Winter K, Harriman K, Schechter R, et al. Notes from the field: Pertussis--California, January-June 2010. MMWR Morb Mortal Wkly Rep 2010; 59:817.</a></li><li class="breakAll">Centers for Disease Control and Prevention. Pertussis (Whooping cough): Pertussis cases by year (1922-2015). https://www.cdc.gov/pertussis/surv-reporting/cases-by-year.html (Accessed on August 15, 2017).</li><li><a class="nounderline abstract_t">Skoff TH, Hadler S, Hariri S. The Epidemiology of Nationally Reported Pertussis in the United States, 2000-2016. Clin Infect Dis 2019; 68:1634.</a></li><li><a class="nounderline abstract_t">Chlibek R, Smetana J, Sosovickova R, et al. Seroepidemiology of whooping cough in the Czech Republic: estimates of incidence of infection in adults. Public Health 2017; 150:77.</a></li><li><a class="nounderline abstract_t">Daluwatte C, Dvaretskaya M, Ekhtiari S, et al. Development of an algorithm for finding pertussis episodes in a population-based electronic health record database. Hum Vaccin Immunother 2023; 19:2209455.</a></li><li><a class="nounderline abstract_t">Macina D, Mathur S, Dvaretskaya M, et al. Estimating the pertussis burden in adolescents and adults in the United States between 2007 and 2019. Hum Vaccin Immunother 2023; 19:2208514.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Pertussis epidemic--Washington, 2012. MMWR Morb Mortal Wkly Rep 2012; 61:517.</a></li><li><a class="nounderline abstract_t">Cherry JD. The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection. Pediatrics 2005; 115:1422.</a></li><li><a class="nounderline abstract_t">Cherry JD. The present and future control of pertussis. Clin Infect Dis 2010; 51:663.</a></li><li><a class="nounderline abstract_t">Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1997; 46:1.</a></li><li><a class="nounderline abstract_t">LAMBERT HJ. EPIDEMIOLOGY OF A SMALL PERTUSSIS OUTBREAK IN KENT COUNTY, MICHIGAN. Public Health Rep 1965; 80:365.</a></li><li><a class="nounderline abstract_t">Jenkinson D. Duration of effectiveness of pertussis vaccine: evidence from a 10 year community study. Br Med J (Clin Res Ed) 1988; 296:612.</a></li><li><a class="nounderline abstract_t">Cody CL, Baraff LJ, Cherry JD, et al. Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics 1981; 68:650.</a></li><li><a class="nounderline abstract_t">Zhang L, Prietsch SO, Axelsson I, Halperin SA. Acellular vaccines for preventing whooping cough in children. Cochrane Database Syst Rev 2014; :CD001478.</a></li><li><a class="nounderline abstract_t">Fulton TR, Phadke VK, Orenstein WA, et al. Protective Effect of Contemporary Pertussis Vaccines: A Systematic Review and Meta-analysis. Clin Infect Dis 2016; 62:1100.</a></li><li><a class="nounderline abstract_t">Clark TA, Messonnier NE, Hadler SC. Pertussis control: time for something new? Trends Microbiol 2012; 20:211.</a></li><li><a class="nounderline abstract_t">Witt MA, Katz PH, Witt DJ. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak. Clin Infect Dis 2012; 54:1730.</a></li><li><a class="nounderline abstract_t">Klein NP, Bartlett J, Rowhani-Rahbar A, et al. Waning protection after fifth dose of acellular pertussis vaccine in children. N Engl J Med 2012; 367:1012.</a></li><li><a class="nounderline abstract_t">Misegades LK, Winter K, Harriman K, et al. Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010. JAMA 2012; 308:2126.</a></li><li><a class="nounderline abstract_t">Tartof SY, Lewis M, Kenyon C, et al. Waning immunity to pertussis following 5 doses of DTaP. Pediatrics 2013; 131:e1047.</a></li><li><a class="nounderline abstract_t">Wessels MR, Brigham KS, DeMaria A Jr. Case records of the Massachusetts General Hospital. Case 6-2015. A 16-year-old boy with coughing spells. N Engl J Med 2015; 372:765.</a></li><li><a class="nounderline abstract_t">Klein NP, Bartlett J, Fireman B, et al. Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers. Pediatrics 2013; 131:e1716.</a></li><li><a class="nounderline abstract_t">Witt MA, Arias L, Katz PH, et al. Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US cohort. Clin Infect Dis 2013; 56:1248.</a></li><li><a class="nounderline abstract_t">Skoff TH, Martin SW. Impact of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccinations on Reported Pertussis Cases Among Those 11 to 18 Years of Age in an Era of Waning Pertussis Immunity: A Follow-up Analysis. JAMA Pediatr 2016; 170:453.</a></li><li class="breakAll">Centers for Disease Control and Prevention. Pertussis (Whooping Cough). Pertussis in Other Countries. https://www.cdc.gov/pertussis/countries/index.html (Accessed on November 28, 2018).</li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Pertussis--United States, 2001-2003. MMWR Morb Mortal Wkly Rep 2005; 54:1283.</a></li><li><a class="nounderline abstract_t">Güriş D, Strebel PM, Bardenheier B, et al. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis 1999; 28:1230.</a></li><li><a class="nounderline abstract_t">Dworkin MS. Adults are whooping, but are internists listening? Ann Intern Med 2005; 142:832.</a></li><li><a class="nounderline abstract_t">Hewlett EL, Edwards KM. Clinical practice. Pertussis--not just for kids. N Engl J Med 2005; 352:1215.</a></li><li><a class="nounderline abstract_t">Tanaka M, Vitek CR, Pascual FB, et al. Trends in pertussis among infants in the United States, 1980-1999. JAMA 2003; 290:2968.</a></li><li><a class="nounderline abstract_t">Vitek CR, Pascual FB, Baughman AL, Murphy TV. Increase in deaths from pertussis among young infants in the United States in the 1990s. Pediatr Infect Dis J 2003; 22:628.</a></li><li class="breakAll">Centers for Disease Control and Prevention. Pertussis (Whooping Cough). Outbreaks. https://www.cdc.gov/pertussis/outbreaks/about.html (Accessed on November 28, 2018).</li><li><a class="nounderline abstract_t">von König CH, Halperin S, Riffelmann M, Guiso N. Pertussis of adults and infants. Lancet Infect Dis 2002; 2:744.</a></li><li><a class="nounderline abstract_t">Teepe J, Broekhuizen BD, Ieven M, et al. Prevalence, diagnosis, and disease course of pertussis in adults with acute cough: a prospective, observational study in primary care. Br J Gen Pract 2015; 65:e662.</a></li><li><a class="nounderline abstract_t">Wehlin L, Ljungman M, Kühlmann-Berenzon S, et al. Pertussis seroprevalence among adults of reproductive age (20-39 years) in fourteen European countries. APMIS 2021; 129:556.</a></li><li><a class="nounderline abstract_t">Nelson JD. The changing epidemiology of pertussis in young infants. The role of adults as reservoirs of infection. Am J Dis Child 1978; 132:371.</a></li><li><a class="nounderline abstract_t">Bisgard KM, Pascual FB, Ehresmann KR, et al. Infant pertussis: who was the source? Pediatr Infect Dis J 2004; 23:985.</a></li><li><a class="nounderline abstract_t">Wendelboe AM, Njamkepo E, Bourillon A, et al. Transmission of Bordetella pertussis to young infants. Pediatr Infect Dis J 2007; 26:293.</a></li><li><a class="nounderline abstract_t">Kowalzik F, Barbosa AP, Fernandes VR, et al. Prospective multinational study of pertussis infection in hospitalized infants and their household contacts. Pediatr Infect Dis J 2007; 26:238.</a></li><li><a class="nounderline abstract_t">Edwards KM. Overview of pertussis: focus on epidemiology, sources of infection, and long term protection after infant vaccination. Pediatr Infect Dis J 2005; 24:S104.</a></li><li><a class="nounderline abstract_t">Fedele G, Carollo M, Palazzo R, et al. Parents as source of pertussis transmission in hospitalized young infants. Infection 2017; 45:171.</a></li><li><a class="nounderline abstract_t">Skoff TH, Kenyon C, Cocoros N, et al. Sources of Infant Pertussis Infection in the United States. Pediatrics 2015; 136:635.</a></li><li><a class="nounderline abstract_t">Warfel JM, Zimmerman LI, Merkel TJ. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc Natl Acad Sci U S A 2014; 111:787.</a></li><li><a class="nounderline abstract_t">Althouse BM, Scarpino SV. Asymptomatic transmission and the resurgence of Bordetella pertussis. BMC Med 2015; 13:146.</a></li><li><a class="nounderline abstract_t">Zerbo O, Fireman B, Klein NP. Lessons from a mature acellular pertussis vaccination program and strategies to overcome suboptimal vaccine effectiveness. Expert Rev Vaccines 2022; 21:899.</a></li><li><a class="nounderline abstract_t">Macina D, Evans KE. Bordetella pertussis in School-Age Children, Adolescents and Adults: A Systematic Review of Epidemiology and Mortality in Europe. Infect Dis Ther 2021; 10:2071.</a></li><li><a class="nounderline abstract_t">Carrico J, Talbird SE, La EM, et al. Cost-benefit analysis of vaccination against four preventable diseases in older adults: Impact of an aging population. Vaccine 2021; 39:5187.</a></li><li><a class="nounderline abstract_t">Williams WW, Lu PJ, O'Halloran A, et al. Surveillance of Vaccination Coverage among Adult Populations - United States, 2015. MMWR Surveill Summ 2017; 66:1.</a></li><li><a class="nounderline abstract_t">Torzsa P, Devadiga R, Tafalla M. Seroprevalence of Bordetella pertussis antibodies in adults in Hungary: results of an epidemiological cross-sectional study. BMC Infect Dis 2017; 17:242.</a></li><li><a class="nounderline abstract_t">Mbayei SA, Faulkner A, Miner C, et al. Severe Pertussis Infections in the United States, 2011-2015. Clin Infect Dis 2019; 69:218.</a></li><li><a class="nounderline abstract_t">Liu BC, McIntyre P, Kaldor JM, et al. Pertussis in older adults: prospective study of risk factors and morbidity. Clin Infect Dis 2012; 55:1450.</a></li><li><a class="nounderline abstract_t">Wensley A, Hughes GJ, Campbell H, et al. Risk factors for pertussis in adults and teenagers in England. Epidemiol Infect 2017; 145:1025.</a></li><li><a class="nounderline abstract_t">Peer V, Schwartz N, Green MS. A multi-country, multi-year, meta-analytic evaluation of the sex differences in age-specific pertussis incidence rates. PLoS One 2020; 15:e0231570.</a></li><li><a class="nounderline abstract_t">Paddock CD, Sanden GN, Cherry JD, et al. Pathology and pathogenesis of fatal Bordetella pertussis infection in infants. Clin Infect Dis 2008; 47:328.</a></li><li><a class="nounderline abstract_t">Christie CD, Baltimore RS. Pertussis in neonates. Am J Dis Child 1989; 143:1199.</a></li><li><a class="nounderline abstract_t">Smith C, Vyas H. Early infantile pertussis; increasingly prevalent and potentially fatal. Eur J Pediatr 2000; 159:898.</a></li><li><a class="nounderline abstract_t">Pawloski LC, Queenan AM, Cassiday PK, et al. Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States. Clin Vaccine Immunol 2014; 21:119.</a></li><li><a class="nounderline abstract_t">Martin SW, Pawloski L, Williams M, et al. Pertactin-negative Bordetella pertussis strains: evidence for a possible selective advantage. Clin Infect Dis 2015; 60:223.</a></li></ol></div><div id="topicVersionRevision">Topic 8043 Version 44.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26977422" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Chao Yuanfang: Imperial Physician of the Sui Dynasty and an Early Pertussis Observer?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26977422" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Chao Yuanfang: Imperial Physician of the Sui Dynasty and an Early Pertussis Observer?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15831828" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22156857" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Patterns of Bordetella parapertussis respiratory illnesses: 2008-2010.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26113655" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Widespread Bordetella parapertussis Infections-Wisconsin, 2011-2012: Clinical and Epidemiologic Features and Antibiotic Use for Treatment and Prevention.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1889042" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Human infections associated with Bordetella bronchiseptica.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7699023" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Bordetella holmesii sp. nov., a new gram-negative species associated with septicemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10341183" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Bordetella holmesii-like organisms isolated from Massachusetts patients with pertussis-like symptoms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23087388" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Epidemiologic and laboratory features of a large outbreak of pertussis-like illnesses associated with cocirculating Bordetella holmesii and Bordetella pertussis--Ohio, 2010-2011.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24092805" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Bordetella holmesii bacteremia cases in the United States, April 2010-January 2011.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24721229" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Bordetella holmesii: an under-recognised Bordetella species.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22807521" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Airborne transmission of Bordetella pertussis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8589145" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Household contact study of Bordetella pertussis infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31257450" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Asymptomatic Infection and Transmission of Pertussis in Households: A Systematic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16340941" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis: 2005 CDC Guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2885802" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Erythromycin in the treatment of pertussis: a study of bacteriologic and clinical effects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4310467" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Antimicrobial treatment of pertussis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11837909" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Pertussis--United States, 1997-2000.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1554832" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : A search for Bordetella pertussis infection in university students.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26621328" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Eight-Year Review of Bordetella pertussis Testing Reveals Seasonal Pattern in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32620085" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Seasonal Bordetella pertussis pattern in the period from 2008 to 2018 in Germany.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32620085" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Seasonal Bordetella pertussis pattern in the period from 2008 to 2018 in Germany.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Notes from the field: Pertussis--California, January-June 2010.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Notes from the field: Pertussis--California, January-June 2010.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30169627" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : The Epidemiology of Nationally Reported Pertussis in the United States, 2000-2016.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28646697" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Seroepidemiology of whooping cough in the Czech Republic: estimates of incidence of infection in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37171155" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Development of an algorithm for finding pertussis episodes in a population-based electronic health record database.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37171153" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Estimating the pertussis burden in adolescents and adults in the United States between 2007 and 2019.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22810264" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Pertussis epidemic--Washington, 2012.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15867059" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20704492" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : The present and future control of pertussis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9091780" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP)</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14279983" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : EPIDEMIOLOGY OF A SMALL PERTUSSIS OUTBREAK IN KENT COUNTY, MICHIGAN.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3126927" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Duration of effectiveness of pertussis vaccine: evidence from a 10 year community study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7031583" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25228233" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Acellular vaccines for preventing whooping cough in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26908803" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Protective Effect of Contemporary Pertussis Vaccines: A Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22494804" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Pertussis control: time for something new?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22423127" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22970945" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Waning protection after fifth dose of acellular pertussis vaccine in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23188029" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23478868" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Waning immunity to pertussis following 5 doses of DTaP.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25693017" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Case records of the Massachusetts General Hospital. Case 6-2015. A 16-year-old boy with coughing spells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23690518" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23487373" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27018748" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Impact of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccinations on Reported Pertussis Cases Among Those 11 to 18 Years of Age in an Era of Waning Pertussis Immunity: A Follow-up Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27018748" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Impact of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccinations on Reported Pertussis Cases Among Those 11 to 18 Years of Age in an Era of Waning Pertussis Immunity: A Follow-up Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16371944" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Pertussis--United States, 2001-2003.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10451158" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15897533" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Adults are whooping, but are internists listening?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15788498" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Clinical practice. Pertussis--not just for kids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14665658" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Trends in pertussis among infants in the United States, 1980-1999.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12867839" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Increase in deaths from pertussis among young infants in the United States in the 1990s.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12867839" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Increase in deaths from pertussis among young infants in the United States in the 1990s.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12467690" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Pertussis of adults and infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26412843" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Prevalence, diagnosis, and disease course of pertussis in adults with acute cough: a prospective, observational study in primary care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34120372" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Pertussis seroprevalence among adults of reproductive age (20-39 years) in fourteen European countries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/645653" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : The changing epidemiology of pertussis in young infants. The role of adults as reservoirs of infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15545851" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Infant pertussis: who was the source?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17414390" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Transmission of Bordetella pertussis to young infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17484221" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Prospective multinational study of pertussis infection in hospitalized infants and their household contacts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15931137" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Overview of pertussis: focus on epidemiology, sources of infection, and long term protection after infant vaccination.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27614887" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Parents as source of pertussis transmission in hospitalized young infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26347437" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Sources of Infant Pertussis Infection in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24277828" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26103968" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Asymptomatic transmission and the resurgence of Bordetella pertussis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34555994" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Lessons from a mature acellular pertussis vaccination program and strategies to overcome suboptimal vaccine effectiveness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34435338" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Bordetella pertussis in School-Age Children, Adolescents and Adults: A Systematic Review of Epidemiology and Mortality in Europe.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34334253" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Cost-benefit analysis of vaccination against four preventable diseases in older adults: Impact of an aging population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28472027" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Surveillance of Vaccination Coverage among Adult Populations - United States, 2015.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28376739" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Seroprevalence of Bordetella pertussis antibodies in adults in Hungary: results of an epidemiological cross-sectional study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30321305" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Severe Pertussis Infections in the United States, 2011-2015.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22806592" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Pertussis in older adults: prospective study of risk factors and morbidity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28065204" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Risk factors for pertussis in adults and teenagers in England.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32324790" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : A multi-country, multi-year, meta-analytic evaluation of the sex differences in age-specific pertussis incidence rates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18558873" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Pathology and pathogenesis of fatal Bordetella pertussis infection in infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2801662" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Pertussis in neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11131347" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Early infantile pertussis; increasingly prevalent and potentially fatal.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24256623" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25301209" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Pertactin-negative Bordetella pertussis strains: evidence for a possible selective advantage.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
